Completed OBSERVATIONAL NCT01865799

A Prospective, Observational, Drug Utilization Study of Subjects Taking Truvada for Pre-exposure Prophylaxis in the USA

Sponsor: Gilead Sciences

Conditions Pre-exposure Prophylaxis for Prevention of HIV Infection

Updated 7 times since 2017 Last updated: Mar 26, 2018 Started: Apr 22, 2013 Primary completion: Jan 22, 2018 Completion: Jan 22, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Pre-exposure Prophylaxis for Prevention of HIV Infection and is currently completed. Gilead Sciences leads this study, which shows 7 recorded versions since 2013 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Status: Active Not Recruiting → Completed · Phase: NA → None

▶ Show 2 earlier versions

Mar 2018 — Apr 2018 [monthly]

Active Not Recruiting NA
Jan 2017 — Mar 2018 [monthly]

Active Not Recruiting NA

First recorded

Apr 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Gilead Sciences

Data source: Gilead Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Foster City, United States